Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer

Hiroko Yamashita(Nagoya City University), Hirotaka Iwase(Kumamoto University)
Breast Cancer Research
July 27, 2005
Cited by 103


Related Papers